CANBERRA, June 17 (Xinhua) -- Australian Health Minister Greg Hunt said on Thursday that the Australian Technical Advisory Group on Immunisation (ATAGI) has advised that the AstraZeneca COVID-19 vaccine be administered to people aged 60 and over, rather than those aged 50 and over as was pr...
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AstraZeneca has begun a global withdrawal of its COVID-19 vaccine. Its vaccine, called Vaxzevria, will no longer be distributed in the European Union. 中文版本今日新闻图件。 A AstraZeneca has begun a global withdrawal of its COVID-19 vaccine. Its vaccine, called Vaxzevria, will no longer...
In a statement, AstraZeneca said the decision was made because there is now a variety of newer vaccines available that have been adapted to target COVID-19 variants. This has led to a decline in demand for the AstraZeneca vaccine, which is no longer being manufactured or supplied. Last yea...
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age and older, including those over 65.
Greg Hunt getting his first shot of the dubious AstraZeneca COVID-19 vaccine. Something tells me he won't be going back for his second shot. Into Denial Mode, As Usual The ABCstates"It's not known how or where Mr Hunt may have developed the bacterial infection." ...
AstraZeneca's COVID-19 vaccine has been recommended for conditional marketing authorisation (CMA) in the European Union (EU) for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older.
Vaxzevria is one of four vaccines authorised in the EU for protecting against COVID-19. Studies show that it is effective at preventing the disease. It also reduces the risk of hospitalisation and deaths from COVID-19. As for all vaccines, E...
AstraZeneca reported Mondaythat its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could have helped rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S. ...
South Africa announced this week that it’s stopping the use of the AstraZeneca-Oxford COVID-19 vaccine after a small study found that it wasn’t effective against mild and moderate disease. Other vaccines are also less effective in South Africa, where a variant of the virus with mutations ...